AIM Stock Analysis: Buy, Sell, or Hold?
AIM - AIM ImmunoTech Inc.
$0.24
-0.01 (-3.79%)
▼
5d:
-5.62%
30d:
-53.71%
90d:
-76.81%
HOLD
MODERATE Confidence
Analysis Updated: May 21, 2026 12:00 AM ET
Earnings: May 21, 2026
0d
Get Alerted When AIM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
11 traders called AIM this week
92% bullish • 2 bearish
92% bullish • 2 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: AIM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: AIM shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: AIM is currently trading at $0.24, which is considered oversold relative to its 30-day fair value range of $0.34 to $0.56.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.21, while resistance sits at $0.69. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: AIM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.75 (+2261.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, AIM is in a strong downtrend. Immediate support is located at $0.21, while resistance sits at $0.69. Short-term momentum is weak, with the stock down 3.8% recently.
Market Sentiment: AIM has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $5.75 (+2261.4%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.34 -
$0.56
Company Quality Score
48/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
47.4%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BEARISH: Downward momentum (-3.8%)
- BULLISH: Trading 2261.4% below Wall St target ($5.75)
- CAUTION: 5-day price weakness (-5.6%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$0.34 -
$0.56
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.21
Resistance Level
$0.69
Current Trend
Strong Downtrend
Technical data as of
May 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-0.17
Wall Street Target
$5.75
(+2261.4%)
Revenue Growth (YoY)
-53.3%
Share & Embed Analysis
Last updated: May 21, 2026 11:47 PM ET
Data refreshes hourly during market hours. Next update: 12:47 AM
Data refreshes hourly during market hours. Next update: 12:47 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AIM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$55 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$52 | 51 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$242 | 63 BUY |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$118 | 55 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
19 analysts |
$92 | 52 HOLD |
